Editorial: Advances in the research of diabetic nephropathy, volume II
暂无分享,去创建一个
[1] Y. Ni,et al. Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry , 2023, Frontiers in Endocrinology.
[2] J. Ming,et al. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy , 2022, Frontiers in Endocrinology.
[3] Zhimin Wang,et al. Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells , 2022, Frontiers in Endocrinology.
[4] Xiangmei Chen,et al. Primary cilium in kidney development, function and disease , 2022, Frontiers in Endocrinology.
[5] Junya Jia,et al. Exploring the pathogenesis of diabetic kidney disease by microarray data analysis , 2022, Frontiers in Pharmacology.
[6] Shankun Zhao,et al. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy , 2022, Frontiers in Endocrinology.
[7] K. Iizuka,et al. SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient with Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two Drug Classes , 2020, Internal medicine.
[8] Mark E Molitch,et al. Diabetic Kidney Disease: A Report From an ADA Consensus Conference , 2014, Diabetes Care.
[9] I. D. de Boer,et al. Diabetic Kidney Disease: A Report From an ADA Consensus Conference , 2014, Diabetes Care.
[10] B. Rodriguez-Iturbe,et al. The Role of Tubulointerstitial Inflammation in the Progression of Chronic Renal Failure , 2010, Nephron Clinical Practice.
[11] S. Ricardo,et al. Renal primary cilia lengthen after acute tubular necrosis. , 2009, Journal of the American Society of Nephrology : JASN.